Aptose Biosciences
APTO
A$2.62
Share price
0.00%
Change (1 day)
201.24%
Change (1 year)
Categories
Revenue for Aptose Biosciences (APTO)
Revenue in 2025 (TTM): N/A
In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Aptose Biosciences from 1998 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2025 (TTM)  | N/A | |
| 2024 | N/A | |
| 2023 | N/A | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | -100% |
| 2010 | A$0 M | -99.18% |
| 2009 | A$0.28 M | 307.2% |
| 2008 | A$0.06 M | -39.62% |
| 2007 | A$0.11 M | 111.7% |
| 2006 | A$0.05 M | 399.97% |
| 2005 | A$0.01 M | -360.12% |
| 2004 | -A$0.01 Million | -100.61% |
| 2003 | A$0.68 M | |
| 2000 | A$0 M | -98.84% |
| 1999 | A$0.3 M | -4.17% |
| 1998 | A$0.32 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Advaxis ADXS | A$0.17 M | N/A | 🇺🇸 USA |
 Corbus Pharmaceuticals
CRBP | N/A | N/A | 🇺🇸 USA |
 ImmunoGen
IMGN | A$0.44 B | N/A | 🇺🇸 USA |